Cannabis
The Europe cannabis testing market is expected to reach US$ 770.30 million by 2027 from US$ 431.58 million in 2019
New York, Jan. 15, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Europe Cannabis Testing Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by Product ; Service ; End User, and Country” – https://www.reportlinker.com/p06004156/?utm_source=GNW
However, the cannabis used as a street drug and trouble with CBD oil are the factors negatively impacting the growth of the market in the coming years.
With the legalization of Cannabis in Europe, producers are looking for a quick and accurate means of determining their products’ quality and potency.The growing use of Cannabis results in increasing demand for Cannabis testing, which, in turn promotes the research activities in the region.
The European Parliament is calling for an EU-wide policy for medical Cannabis and properly funded scientific research. To achieve this, in February 2019, members of the European Parliament (MEPs) adopted a resolution on the use of Cannabis for medicinal purposes.
Various European countries have legalized the medical use of Cannabis or cannabinoids and are considering their legislation changes for legalization of Cannabis. The main purpose of the resolution is to draw a clear distinction between medical Cannabis and other Cannabis uses.
However, no EU country authorizes the smoking or home-growing of Cannabis for medical purposes.At the same time, the World Health Organization (WHO) has officially recommended that the Cannabis compound cannabidiol (CBD) should not be classified as a controlled substance.
However, at present, there are no EU-wide rules for either the medical or recreational use of Cannabis in the region.
The Cannabis or cannabinoids have therapeutic effects in stimulating appetite and alleviating mental disorders or epilepsy, asthma, cancer, and Alzheimer’s. The MEPs’ primary purpose is to address research gaps on medical Cannabis in the region and call member states to seize the potential of Cannabis-based medicines.
Thus, the need for more research in the therapeutic area and stimulating innovation regarding medicinal Cannabis projects is expected to witness rapid growth of the market in the region.
Based on product, the Europe cannabis testing market is segmented into chromatography instruments, spectroscopy, consumables, and software.The market players are offering diverse portfolio of cannabis testing products to the healthcare industry for innovations in the technologies.
In 2019, the chromatography instruments segment held the largest share of the market and is expected to witness the highest CAGR in the market owing to increasing analytical services and medicinal cannabis testing services.
Based on service, the European cannabis market is segmented into potency testing, microbial analysis, residual solvent screening, heavy metal testing, pesticide screening, terpene profiling, and genetic testing. In 2019, potency testing segment held the largest share of the market, and is expected to grow at the fastest rate during the coming years.
Based on end user, the Europe cannabis testing market is segmented into testing laboratories, drug manufacturers, and research institutes.In 2019, the testing laboratories segment held the largest share of the market, and is expected to grow at the fastest rate during the coming years.
The growth of the segment is attributed to the increasing number of diagnostic testing performed in the reference labs for numerous diseases.
National Research Foundation, National Center for Biotechnology Information, and European Union and National Science Foundation are among the major primary and secondary sources for the Europe Cannabis testing market.
Read the full report: https://www.reportlinker.com/p06004156/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Cannabis
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
SCHWAZZE2 weeks ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis6 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis5 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan5 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey